Tags

Type your tag names separated by a space and hit enter

Advances in pump technology: insulin patch pumps, combined pumps and glucose sensors, and implanted pumps.
Diabetes Metab. 2011 Dec; 37 Suppl 4:S85-93.DM

Abstract

This review discusses the most recent developments in insulin pump technology. The benefits of the insulin pump to patients with type 1 diabetes are recognized both for its metabolic effectiveness and its positive effects on quality of life. The current pumps are reliable, small and light, and are becoming more and more sophisticated. Nevertheless, there remain practical and psychological constraints for the patient. However, recent patch-pump advances should simplify the technical aspects of pump treatment and enhance patient comfort. Another advance combines the insulin pump with a glucose sensor. Such a combination is logical for optimizing pump use and, to that end, developing an automated or 'closed-loop'system that permits the delivery of subcutaneous insulin adjusted according to measured levels of subcutaneous glucose. Finally, implanted insulin pumps have proven their worth not only because of their simple use, but also for their contribution in the artificial pancreas project. Indeed, the prompt response with intraperitoneal administration of insulin makes it of interest for use in a closed-loop system.

Authors+Show Affiliations

Service d'endocrinologie, nutrition et maladies métaboliques, CHU-Hôpitaux sud, 270, Boulevard de Sainte Marguerite, 13009 Marseille, France. pauline.schaepelynck@ap-hm.frNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

22208717

Citation

Schaepelynck, P, et al. "Advances in Pump Technology: Insulin Patch Pumps, Combined Pumps and Glucose Sensors, and Implanted Pumps." Diabetes & Metabolism, vol. 37 Suppl 4, 2011, pp. S85-93.
Schaepelynck P, Darmon P, Molines L, et al. Advances in pump technology: insulin patch pumps, combined pumps and glucose sensors, and implanted pumps. Diabetes Metab. 2011;37 Suppl 4:S85-93.
Schaepelynck, P., Darmon, P., Molines, L., Jannot-Lamotte, M. F., Treglia, C., & Raccah, D. (2011). Advances in pump technology: insulin patch pumps, combined pumps and glucose sensors, and implanted pumps. Diabetes & Metabolism, 37 Suppl 4, S85-93. https://doi.org/10.1016/S1262-3636(11)70972-7
Schaepelynck P, et al. Advances in Pump Technology: Insulin Patch Pumps, Combined Pumps and Glucose Sensors, and Implanted Pumps. Diabetes Metab. 2011;37 Suppl 4:S85-93. PubMed PMID: 22208717.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Advances in pump technology: insulin patch pumps, combined pumps and glucose sensors, and implanted pumps. AU - Schaepelynck,P, AU - Darmon,P, AU - Molines,L, AU - Jannot-Lamotte,M F, AU - Treglia,C, AU - Raccah,D, PY - 2012/1/3/entrez PY - 2012/1/3/pubmed PY - 2012/6/8/medline SP - S85 EP - 93 JF - Diabetes & metabolism JO - Diabetes Metab VL - 37 Suppl 4 N2 - This review discusses the most recent developments in insulin pump technology. The benefits of the insulin pump to patients with type 1 diabetes are recognized both for its metabolic effectiveness and its positive effects on quality of life. The current pumps are reliable, small and light, and are becoming more and more sophisticated. Nevertheless, there remain practical and psychological constraints for the patient. However, recent patch-pump advances should simplify the technical aspects of pump treatment and enhance patient comfort. Another advance combines the insulin pump with a glucose sensor. Such a combination is logical for optimizing pump use and, to that end, developing an automated or 'closed-loop'system that permits the delivery of subcutaneous insulin adjusted according to measured levels of subcutaneous glucose. Finally, implanted insulin pumps have proven their worth not only because of their simple use, but also for their contribution in the artificial pancreas project. Indeed, the prompt response with intraperitoneal administration of insulin makes it of interest for use in a closed-loop system. SN - 1878-1780 UR - https://www.unboundmedicine.com/medline/citation/22208717/Advances_in_pump_technology:_insulin_patch_pumps_combined_pumps_and_glucose_sensors_and_implanted_pumps_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S1262-3636(11)70972-7 DB - PRIME DP - Unbound Medicine ER -